-
Moderna information chief to retire next month; Pharming looks to Flagship for first new CEO since 2008
24 Jan 2025 13:19 GMT
-
Pharming to nominate Fabrice Chouraqui as new executive director and chief executive officer
22 Jan 2025 05:54 GMT
… officer, succeeding Sijmen de Vries.
Pharming will nominate Chouraqui for the … highly innovative biotechnology companies to Pharming.
To make way for Fabrice … , debilitating, and life-threatening diseases. Pharming is commercializing and developing an …
-
Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer
21 Jan 2025 06:00 GMT
… . For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael … 27
E: pharming@lifespring.nl About Pharming Group N.V.
Pharming Group N … , debilitating, and life-threatening diseases. Pharming is commercializing and developing an …
-
‘Unfortunately, 50% of all claims...’: ‘Food Pharmer’ sheds light on hidden practices in health insurance industry
19 Jan 2025 11:59 GMT
… Himatsingka, popularly known as Food Pharmer, shed light on the hidden … /aVBEDFQgCU
— Revant Himatsingka “Food Pharmer” (@foodpharmer2) January 19, 2025
In … , popularly known as the ‘Food Pharmer’ is a certified health coach …
-
Pharming Group N.V.: Innovation in Treating Rare Diseases
15 Jan 2025 18:56 GMT
… .
A Pioneer in Biopharmaceutical Solutions
Pharming Group N.V. operates across … Through Joenja® and Regional Operations
Pharming Group continues to diversify its … systems. This global presence underscores Pharming’s dedication to improving accessibility …
-
Pharming Announces Public Cash Offer To The Shareholders Of Abliva AB
15 Dec 2024 19:57 GMT
… from a financial perspective. Pharming has obtained acceptance undertakings from … further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael … debilitating, and life-threatening diseases. Pharming is commercializing and developing an …
-
Critical Insights From Pharming Analyst Ratings: What You Need To Know
09 Dec 2024 12:29 GMT
… how financial experts perceive Pharming. The following summary outlines … recent developments related to Pharming. This information offers a …
A Deep Dive into Pharming's Financials
Market … prominence.
Revenue Growth: Pharming displayed positive results in …
-
Pharming Group reports third quarter 2024 financial results and provides business update
24 Oct 2024 05:00 GMT
… leniolisib, thereby ensuring Pharming is delivering on its … deadline. In addition, Pharming progressed ongoing clinical … pharming@lifespring.nl About Pharming Group N.V. Pharming Group … and life-threatening diseases. Pharming is commercializing and developing …
-
Pharming Group to report third quarter 2024 financial results on October 24
10 Oct 2024 06:00 GMT
… , October 10, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM … debilitating, and life-threatening diseases. Pharming is commercializing and developing an … further public information, contact: Pharming Group, Leiden, the Netherlands
Michael …
-
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation
10 Oct 2024 05:00 GMT
… debilitating, and life-threatening diseases. Pharming is commercializing and developing an … small molecules and biologics. Pharming is headquartered in Leiden, the … For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael …
About
© 1995-2025